Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
Cardiorenal syndrome is a term that defines the complex bidirectional nature of the interaction between cardiac and renal disease. It is well established that patients with kidney disease have higher incidence of cardiovascular comorbidities and that renal dysfunction is a significant threat to the...
Main Authors: | Beatriz Delgado-Valero, Victoria Cachofeiro, Ernesto Martínez-Martínez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/7/1824 |
Similar Items
-
Editorial: New Advances in Cardiorenal Syndrome
by: Laurent Calvier, et al.
Published: (2022-07-01) -
Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities
by: Xia Xu, et al.
Published: (2023-08-01) -
The Diabetic Cardiorenal Nexus
by: John A. D’Elia, et al.
Published: (2022-07-01) -
Cardiorenal syndrome in thalassemia patients
by: Sorasak Makmettakul, et al.
Published: (2020-08-01) -
Cardiorenal syndrome and diabetes: an evil pairing
by: Ana Belén Méndez Fernández, et al.
Published: (2023-05-01)